What is Insulin Glargine-Lixisenatide?

Category: Prescription Drugs

Most popular types: Soliqua

false

Insulin Glargine-Lixisenatide is a combination medication of insulin glargine and lixisenatide. It is a treatment for blood glucose control in adults living with type 2 diabetes.

Dosages

Based on patients currently taking Insulin Glargine-Lixisenatide

Dosage Patients Percentage
100-0.033 var units daily 1

Why patients stopped taking Insulin Glargine-Lixisenatide

Multiple reasons could be selected

Reason Patients Percentage
Change in health plan coverage 1
See 1 patient who's stopped taking Insulin Glargine-Lixisenatide

Duration

Currently taking Insulin Glargine-Lixisenatide

Duration Patients Percentage
2 - 5 years 1

Stopped taking Insulin Glargine-Lixisenatide

Duration Patients Percentage
6 months - 1 year 1
1 - 2 years 1

What people switch to and from

Patients started taking Insulin Glargine-Lixisenatide after stopping:

Treatment Patients Percentage
Insulin Glargine (Lantus) 2

Patients stopped taking Insulin Glargine-Lixisenatide and switched to:

Treatment Patients Percentage
Dulaglutide (Trulicity) 1
Insulin Glargine (Lantus) 1
Last updated:
There are no evaluations for Insulin Glargine-Lixisenatide.